// App-Quantinova.ai

: Incidence and costs associated with clinically significant events in real-world patients with unresectable hepatocellular carcinoma on systemic therapy.

Researchers

Presenter

  • Marcus Healey

Principal Investigators

  • Daniel Simmons

  • Stephen J Valerio

  • Janvi Sah

  • Debra Pierce

  • Zhuoxin Jiang

  • Darren Thomas

  • Jesica Levingston Mac Leod

  • Yian Lin

Medical Centers

  • AstraZeneca, Gaithersburg, MD

  • Pierce MD Consulting LLC, Rockbridge, OH

  • AstraZeneca, South San Francisco, CA

  • Astra Zeneca, Cambridge, United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

Biomarkers

  • N/A

Drug/Treatment

  • Atezolizumab

Outcome

  • N/A

Study Design

  • Observational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved